Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.

Leukemia·2024
Same author

Synthesis of Trifluoromethylated Monoterpenes by an Engineered Cytochrome P450.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023
Same author

Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.

Cancer medicine·2023
Same author

Therapeutic drug monitoring of perospirone: The lowest effective plasma concentration in patients with schizophrenia.

Asian journal of psychiatry·2023
Same author

Insight of the State for Deliberately Introduced A-Site Defect in Nanofibrous LaFeO<sub>3</sub> for Boosting Artificial Photosynthesis of CH<sub>3</sub>OH.

ACS applied materials & interfaces·2023
Same author

Nitrous oxide emissions in novel wastewater treatment processes: A comprehensive review.

Bioresource technology·2023

相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.5K

ZBED4:肝细胞癌的预后生物标志物和治疗标

Jing Ding1, Xia Zou1, Xuefeng Huang1,2

  • 1Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China.

Journal of hepatocellular carcinoma
|August 28, 2025
PubMed
概括

一种蛋白质ZBED4与肝细胞癌 (HCC) 的预后不佳有关,并影响免疫细胞的透. 它可以作为预测HCC患者治疗反应的生物标志物.

关键词:
ZBED4 其他肝细胞癌免疫透胰腺癌预后情况治疗方法

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.0K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.4K

相关实验视频

Last Updated: Sep 9, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.5K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.0K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.4K

科学领域:

  • 癌症学
  • 免疫学
  • 基因组学

背景情况:

  • 肝细胞癌 (HCC) 是癌症相关死亡的主要原因,治疗选择有限.
  • 研究新的治疗目标和策略对于改善HCC的结果至关重要.
  • 尚不清楚ZBED4在癌症发展和进展中的具体作用.

研究的目的:

  • 研究ZBED4在肝细胞癌 (HCC) 中的作用.
  • 评估ZBED4作为HCC的潜在预后和治疗生物标志物.
  • 探索ZBED4表达与瘤免疫微环境之间的关系.

主要方法:

  • 从TCGA,GEO,ICGC和GDSC数据库中进行数据挖掘.
  • 使用R软件和网络平台进行生物信息分析.
  • 使用多重免疫光对HCC组织微阵列进行验证.

主要成果:

  • 在多种癌症中,高ZBED4表达与预后不佳和免疫细胞透的改变有关.
  • 在HCC中,ZBED4水平与CD8+T细胞相反相关,但与Tregs和中性粒细胞相反相关.
  • 在HCC患者中,ZBED4的升高与免疫治疗的反应降低有关,但与化疗和向治疗的反应有所改善.

结论:

  • 在HCC中,ZBED4在调节瘤免疫微环境方面发挥着重要作用.
  • ZBED4作为HCC的潜在预后生物标志物.
  • 可以预测患者对不同治疗策略的反应,包括免疫治疗和化疗.